The $950B health care plan and the top pharmaceutical ETFs

Following president Obama's update on the $950B health care plan, BNN had a segment on pharmaceutical ETFs and how they are being affected.

The two main ETFs in this segment are  PPH and IHE.

PPH is much less diversified, wit its top three holdings representing over 60% of its value, and the top four making up 71.6%. These are the top holdings and their percentages:

• Johnson & Johnson    24.82
• Pfizer Inc    18.86
• Merck & Co    16.79
• Abbott Laboratories    11.2
• Bristol-Myers Squibb Co.    6.73
• Medco Health Solutions, Inc.    5.67
• Lilly (Eli) & Co.    5.29
• Forest Laboratories, Inc.    1.9
• Allergan, Inc    1.87
• Zimmer Holdings, Inc.    1.75

Chart:

IHE Holdings:

• Abbott Laboratories    7.09
• Allergan, Inc    4.64
• Bristol-Myers Squibb Co.    5.19
• Lilly (Eli) & Co.    5.47
• Forest Laboratories, Inc.    3.75
• Hospira Inc    3.6
• Johnson & Johnson    9.14
• Merck & Co., Inc    7.68
• Mylan Inc.    3.09
• Pfizer Inc    8.54

Chart:

BNN also reported on the very high number of options traded on these ETFs.

Watch video